{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:14Z","timestamp":1791244514676,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-026-00599-8","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:53:09Z","timestamp":1783579989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Psoriasis and Prostate Cancer Risk in Men: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-1572","authenticated-orcid":false,"given":"Shih-Wei","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Fu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","volume":"130","author":"S Kagami","year":"2010","unstructured":"Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 2010;130:1373\u201383.","journal-title":"J Invest Dermatol"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1038\/s41598-019-43899-9","volume":"9","author":"SC Furiati","year":"2019","unstructured":"Furiati SC, Catarino JS, Silva MV, Silva RF, Estevam RB, Teodoro RB, et al. Th1, Th17, and Treg Responses are Differently Modulated by TNF-\u03b1 Inhibitors and Methotrexate in Psoriasis Patients. Sci Rep. 2019;9:7526.","journal-title":"Sci Rep"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"16095","DOI":"10.3390\/ijms242216095","volume":"24","author":"AM Man","year":"2023","unstructured":"Man AM, Or\u0103san MS, Hoteiuc OA, Ol\u0103nescu-Vaida-Voevod MC, Mocan T. Inflammation and Psoriasis: A Comprehensive Review. Int J Mol Sci. 2023;24:16095.","journal-title":"Int J Mol Sci"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Callis Duffin K, Huang Y-H, Savage LJ, Guo L, et al. Psoriasis Nat Reviews Disease Primers. 2025;11:45.","journal-title":"Psoriasis Nat Reviews Disease Primers"},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371.","journal-title":"Lancet"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP, Psoriasis. Lancet. 2015;386:983\u201394.","journal-title":"Lancet"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76:377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"599_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.12165","volume":"27","author":"C Pouplard","year":"2013","unstructured":"Pouplard C, Brenaut E, Horreau C, Barnetche T, Misery L, Richard MA, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol. 2013;27(Suppl 3):36\u201346.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamadermatol.2015.4847","volume":"152","author":"ZC Chiesa Fuxench","year":"2016","unstructured":"Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, Gelfand JM. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network. JAMA Dermatol. 2016;152:282\u201390.","journal-title":"JAMA Dermatol"},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","volume":"155","author":"AM Trafford","year":"2019","unstructured":"Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, Ashcroft DM. Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155:1390\u2013403.","journal-title":"JAMA Dermatol"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","volume":"156","author":"S Vaengebjerg","year":"2020","unstructured":"Vaengebjerg S, Skov L, Egeberg A, Loft ND. Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2020;156:421\u20139.","journal-title":"JAMA Dermatol"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019;10:63\u201389.","journal-title":"World J Oncol"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1158\/1055-9965.EPI-19-0412","volume":"29","author":"KH Kensler","year":"2020","unstructured":"Kensler KH, Rebbeck TR. Cancer Progress and Priorities: Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2020;29:267\u201377.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"599_CR15","doi-asserted-by":"publisher","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389. https:\/\/doi.org\/10.1002\/ijc.33588.","DOI":"10.1002\/ijc.33588"},{"key":"599_CR16","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bjd.15830","volume":"178","author":"E Peleva","year":"2018","unstructured":"Peleva E, Exton LS, Kelley K, Kleyn CE, Mason KJ, Smith CH. Risk of cancer in patients with psoriasis on biological therapies: a systematic review. Br J Dermatol. 2018;178:103\u201313.","journal-title":"Br J Dermatol"},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.71079\/ASIDE.IM.03222516","volume":"1","author":"M Nassar","year":"2025","unstructured":"Nassar M, Abosheaishaa H, Elfert K, Beran A, Ismail A, Mohamed M, et al. TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research. ASIDE Intern Med. 2025;1:24\u201333.","journal-title":"ASIDE Intern Med"},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"1516126","DOI":"10.3389\/fphar.2025.1516126","volume":"16","author":"RJ Ludwig","year":"2025","unstructured":"Ludwig RJ, Anson M, Zirpel H, Thaci D, Olbrich H, Bieber K, et al. A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front Pharmacol. 2025;16:1516126.","journal-title":"Front Pharmacol"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298\u2013306.","journal-title":"Nat Rev Cancer"},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjd.12670","volume":"170","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170:304\u201314.","journal-title":"Br J Dermatol"},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2014.08.059","volume":"66","author":"F Islami","year":"2014","unstructured":"Islami F, Moreira DM, Boffetta P, Freedland SJ. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol. 2014;66:1054\u201364.","journal-title":"Eur Urol"},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jid.2018.11.023","volume":"139","author":"K Ogawa","year":"2019","unstructured":"Ogawa K, Stuart PE, Tsoi LC, Suzuki K, Nair RP, Mochizuki H, et al. A Transethnic Mendelian Randomization Study Identifies Causality of Obesity on Risk of Psoriasis. J Invest Dermatol. 2019;139:1397\u2013400.","journal-title":"J Invest Dermatol"},{"key":"599_CR28","first-page":"176","volume":"77","author":"FG Ramadani","year":"2024","unstructured":"Ramadani FG, Perdana NR, Ringoringo DRL. Body mass index, obesity and risk of prostate cancer: a systematic review and meta-analysis. Cent Eur J Urol. 2024;77:176\u201388.","journal-title":"Cent Eur J Urol"},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s44411-026-00489-2","volume":"127","author":"S-W Lai","year":"2026","unstructured":"Lai S-W, Lin C-L, Liao K-F. Association between Psoriasis and Type 2 Diabetes in Adults: A Propensity Score\u2013Matched Cohort Study. Bratislava Med J. 2026;127:1197\u2013203.","journal-title":"Bratislava Med J"},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00345-023-04531-8","volume":"41","author":"S Gomaa","year":"2023","unstructured":"Gomaa S, Kelly WK, Mitchell E, Storozynsky E, Zeigler-Johnson C, Juon HS, et al. Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data. World J Urol. 2023;41:2351\u20137.","journal-title":"World J Urol"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-026-00599-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:19:42Z","timestamp":1791242382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-026-00599-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s44197-026-00599-8","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. This study is exempt from informed consent. The data reviewed represent a secondary analysis of existing data, do not involve intervention or interaction with human subjects, and are de-identified in accordance with the de-identification standard defined in Section \u00a7\u00a0164.514(a) of the HIPAA Privacy Rule. The process by which the data are de-identified is attested to through a formal determination by a qualified expert as defined in Section \u00a7\u00a0164.514(b)(1) of the HIPAA Privacy Rule. This formal determination by a qualified expert was refreshed on December 2020.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}